Current role
Biotechnology · Healthcare
Board Member
2023-04-05–present
Timothy Walbert
Board Member
Mirum Pharmaceuticals, Inc. (MIRM)Equibles does not estimate personal net worth.
Get an email with a short summary when Mirum Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MIRM alertsAbout Timothy Walbert
Timothy Walbert is recorded as Board Member at Mirum Pharmaceuticals, Inc. (MIRM) since April 5, 2023. Mirum Pharmaceuticals, Inc. reported in an 8-K filed April 6, 2023 that Timothy Walbert was appointed Class I director, effective April 5, 2023. Mirum Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mirum Pharmaceuticals, Inc. includes Christopher Peetz (CEO), Michael Grey (CEO), Eric Bjerkholt (CFO) and 5 others.
“On April 5, 2023, the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Timothy Walbert to the Board, effective immediately.”
Affiliation history
-
Current
2023-04-05–present
Company network
Leadership on record at Mirum Pharmaceuticals, Inc.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- To approve Board Member
- William Fairey Board Member